In a recent study published by Nature Communications, researchers uncovered a previously unknown method by which androgen-activated androgen receptors (ARs) increase fucosyltransferase 4 (FUT4) ...
A TTUHSC research team led by Srinivas Nandana, Ph.D., (center) and Manisha Tripathi, Ph.D., (left) recently completed a study focused on uncovering the molecular and signaling mechanisms that drive ...
Clinical Implications of a Large-Scale Voluntary Preemptive DPYD Testing Program for Patients Planned for a Systemic Fluoropyrimidine: Preliminary Results The following represents disclosure ...
3don MSN
Reversing treatment resistance in prostate cancer: Study solves longstanding puzzle in tumor biology
Scientists at the Herbert Irving Comprehensive Cancer Center (HICCC) have discovered a key mechanism that makes prostate cancer cells resistant to the latest drugs used to treat them. Their findings, ...
Combined androgen blockade shows significant survival benefits over single-agent ADT in high-risk prostate cancer, as ...
Dr. Hordinsky discusses how clascoterone 5% topical solution may reshape male AGA management and expand treatment confidence.
Men treated with androgen deprivation therapy (ADT) for prostate cancer had a significantly higher risk of dementia and other neurocognitive disorders, according to a meta-analysis of more than 2.5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback